Ashish Ranjan Dwivedi
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases 10
- Organic Chemistry top 5%
- Synthesis and biological activity 13
- Click Chemistry and Applications 8
- Synthesis and Biological Evaluation 6
- Quinazolinone synthesis and applications 5
- Synthesis and Characterization of Heterocyclic Compounds 4
- Synthesis and Reactions of Organic Compounds 3
-
- Computational Drug Discovery Methods 8
- Co-authors
- Vinod KumarBhupinder KumarRamandeep KaurVijay KumarJyoti ParkashVinay KumarRakesh KumarAmandeep Thakur
- Partner nations
- IndiaUnited StatesNepal
In The Last Decade
Ashish Ranjan Dwivedi
38 papers receiving 814 citations
Peers
Comparison fields: 5 of 81
- Pharmacology 288
- Organic Chemistry 465
- Computational Theory and Mathematics 203
- Complementary and alternative medicine 37
- Rehabilitation 26
Countries citing papers authored by Ashish Ranjan Dwivedi
This map shows the geographic impact of Ashish Ranjan Dwivedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashish Ranjan Dwivedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashish Ranjan Dwivedi more than expected).
Fields of papers citing papers by Ashish Ranjan Dwivedi
This network shows the impact of papers produced by Ashish Ranjan Dwivedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashish Ranjan Dwivedi. The network helps show where Ashish Ranjan Dwivedi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ashish Ranjan Dwivedi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 32 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 17 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 33 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 13 | |
| 14 | 2022 | 65 | |
| 15 | 2022 | 11 | |
| 16 | 2021 | 17 | |
| 17 | 2020 | 40 | |
| 18 | 2020 | 17 | |
| 19 | 2019 | 19 | |
| 20 | 2016 | 7 |
About Ashish Ranjan Dwivedi
Ashish Ranjan Dwivedi is a scholar working on Organic Chemistry, Pharmacology and Toxicology, having authored 45 papers that have together received 828 indexed citations. Recurring topics across this work include Synthesis and biological activity (13 papers), Cholinesterase and Neurodegenerative Diseases (10 papers), Click Chemistry and Applications (8 papers), Computational Drug Discovery Methods (8 papers), Synthesis and Biological Evaluation (6 papers), Quinazolinone synthesis and applications (5 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Synthesis and Reactions of Organic Compounds (3 papers). The work is most often cited by research in Pharmacology (288 citations), Organic Chemistry (465 citations) and Computational Theory and Mathematics (203 citations). Ashish Ranjan Dwivedi has collaborated with scholars based in India, United States and Nepal. Frequent co-authors include Vinod Kumar, Bhupinder Kumar, Ramandeep Kaur, Vijay Kumar, Jyoti Parkash, Vinay Kumar, Rakesh Kumar, Amandeep Thakur, Anil K. Mantha and Sairam Krishnamurthy. Their work appears in journals such as Small, Experimental Cell Research and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.